{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:09:19Z","timestamp":1792782559812,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["FD006007"],"award-info":[{"award-number":["FD006007"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["FD003902"],"award-info":[{"award-number":["FD003902"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Thomas L. Kempner, Jr. Foundation"},{"name":"Simon-Strauss Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00198-026-08061-y","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T12:17:44Z","timestamp":1778501864000},"page":"2063-2072","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Postpartum timing of teriparatide initiation and BMD response in pregnancy- and lactation-associated osteoporosis: an observational study"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3782-4925","authenticated-orcid":false,"given":"Lauren K.","family":"Lynch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mafo","family":"Kamanda-Kosseh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchita","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Shane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Shiau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dany","family":"El-Najjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivelisse","family":"Colon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mildense","family":"Del Orbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Bucovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"8061_CR1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00223-021-00815-6","volume":"110","author":"SA Hardcastle","year":"2022","unstructured":"Hardcastle SA (2022) Pregnancy and lactation associated osteoporosis. Calcif Tissue Int 110:531\u2013545","journal-title":"Calcif Tissue Int"},{"key":"8061_CR2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ecl.2024.05.003","volume":"53","author":"A Cohen","year":"2024","unstructured":"Cohen A (2024) Bone metabolism, bone mass, and bone structure during pregnancy and lactation: normal physiology and pregnancy and lactation-associated osteoporosis. Endocrinol Metab Clin North Am 53:453\u2013470","journal-title":"Endocrinol Metab Clin North Am"},{"key":"8061_CR3","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s00198-023-06793-9","volume":"34","author":"AV Kondapalli","year":"2023","unstructured":"Kondapalli AV, Kamanda-Kosseh M, Williams JM et al (2023) Clinical characteristics of pregnancy and lactation associated osteoporosis: an online survey study. Osteoporos Int 34:1477\u20131489. https:\/\/doi.org\/10.1007\/s00198-023-06793-9","journal-title":"Osteoporos Int"},{"key":"8061_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1612188","author":"G Grassi","year":"2025","unstructured":"Grassi G, Zampogna M, Atlasova A et al (2025) Identifying risk factors for pregnancy and lactation-associated osteoporosis: insights from an Italian survey in PLAO patients and controls. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2025.1612188","journal-title":"Front Endocrinol (Lausanne)"},{"key":"8061_CR5","unstructured":"El-Najjar D, Metzger C, Allen MR et al (2024) Women with pregnancy and lactation associated osteoporosis (PLO) have low bone turnover at multiple postpartum timepoints: a transiliac bone biopsy study. In: ASBMR Annual Meeting, Toronto, Canada"},{"key":"8061_CR6","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1002\/jbmr.3750","volume":"34","author":"A Cohen","year":"2019","unstructured":"Cohen A, Kamanda-Kosseh M, Dempster DW et al (2019) Women with pregnancy and lactation\u2013associated osteoporosis (PLO) have low bone remodeling rates at the tissue level. J Bone Miner Res 34:1552\u20131561. https:\/\/doi.org\/10.1002\/jbmr.3750","journal-title":"J Bone Miner Res"},{"key":"8061_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2025.117744","volume":"204","author":"LK Lynch","year":"2026","unstructured":"Lynch LK, Shea P, Vena N et al (2026) Genetic contributors to osteoporosis in pregnancy and lactation associated osteoporosis (PLO). Bone 204:117744. https:\/\/doi.org\/10.1016\/j.bone.2025.117744","journal-title":"Bone"},{"key":"8061_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.115911","author":"S Butscheidt","year":"2021","unstructured":"Butscheidt S, Tsourdi E, Rolvien T et al (2021) Relevant genetic variants are common in women with pregnancy and lactation-associated osteoporosis (PLO) and predispose to more severe clinical manifestations. Bone. https:\/\/doi.org\/10.1016\/j.bone.2021.115911","journal-title":"Bone"},{"key":"8061_CR9","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2147\/IJWH.S366254","volume":"15","author":"MF Scioscia","year":"2023","unstructured":"Scioscia MF, Zanchetta MB (2023) Recent insights into pregnancy and lactation-associated osteoporosis (PLO). Int J Womens Health 15:1227\u20131238","journal-title":"Int J Womens Health"},{"key":"8061_CR10","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1152\/physrev.00027.2015","volume":"96","author":"CS Kovacs","year":"2016","unstructured":"Kovacs CS (2016) Maternal mineral and bone metabolism during pregnancy, lactation, and post-weaning recovery. Physiol Rev 96:449\u2013547. https:\/\/doi.org\/10.1152\/physrev.00027.2015","journal-title":"Physiol Rev"},{"key":"8061_CR11","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1001\/jama.1993.03500240074029","volume":"269","author":"M Sowers","year":"1993","unstructured":"Sowers M, Corton G, Shapiro B et al (1993) Changes in bone density with lactation. JAMA 269:3130\u20133135","journal-title":"JAMA"},{"key":"8061_CR12","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1007\/s001980170033","volume":"12","author":"C Karlsson","year":"2001","unstructured":"Karlsson C, Obrant KJ, Karlsson M (2001) Pregnancy and lactation confer reversible bone loss in humans. Osteoporos Int 12:828\u2013834","journal-title":"Osteoporos Int"},{"key":"8061_CR13","doi-asserted-by":"crossref","unstructured":"Kolthoff N, Eiken P, Nielsen SP (1998) Bone mineral changes during pregnancy and lactation: a longitudinal cohort study. Clin Sci  94:405-412","DOI":"10.1042\/cs0940405"},{"key":"8061_CR14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1210\/jc.2014-2825","volume":"100","author":"P Brembeck","year":"2015","unstructured":"Brembeck P, Lorentzon M, Ohlsson C et al (2015) Changes in cortical volumetric bone mineral density and thickness, and trabecular thickness in lactating women postpartum. J Clin Endocrinol Metab 100:535\u2013543. https:\/\/doi.org\/10.1210\/jc.2014-2825","journal-title":"J Clin Endocrinol Metab"},{"key":"8061_CR15","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/jbmr.3090","volume":"32","author":"\u00c5 Bj\u00f8rnerem","year":"2017","unstructured":"Bj\u00f8rnerem \u00c5, Ghasem-Zadeh A, Wang X et al (2017) Irreversible deterioration of cortical and trabecular microstructure associated with breastfeeding. J Bone Miner Res 32:681\u2013687. https:\/\/doi.org\/10.1002\/jbmr.3090","journal-title":"J Bone Miner Res"},{"key":"8061_CR16","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1002\/jbmr.3559","volume":"33","author":"CMJ de Bakker","year":"2018","unstructured":"de Bakker CMJ, Li Y, Zhao H et al (2018) Structural adaptations in the rat tibia bone induced by pregnancy and lactation confer protective effects against future estrogen deficiency. J Bone Miner Res 33:2165\u20132176. https:\/\/doi.org\/10.1002\/jbmr.3559","journal-title":"J Bone Miner Res"},{"key":"8061_CR17","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1007\/s00198-011-1790-z","volume":"23","author":"PK Wiklund","year":"2012","unstructured":"Wiklund PK, Xu L, Wang Q et al (2012) Lactation is associated with greater maternal bone size and bone strength later in life. Osteoporos Int 23:1939\u20131945. https:\/\/doi.org\/10.1007\/s00198-011-1790-z","journal-title":"Osteoporos Int"},{"key":"8061_CR18","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1007\/s00198-005-1978-1","volume":"16","author":"B Specker","year":"2005","unstructured":"Specker B, Binkley T (2005) High parity is associated with increased bone size and strength. Osteoporos Int 16:1969\u20131974. https:\/\/doi.org\/10.1007\/s00198-005-1978-1","journal-title":"Osteoporos Int"},{"key":"8061_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-019-0601-6","author":"S Cooke-Hubley","year":"2019","unstructured":"Cooke-Hubley S, Gao Z, Mugford G et al (2019) Parity and lactation are not associated with incident fragility fractures or radiographic vertebral fractures over 16 years of follow-up: Canadian Multicentre Osteoporosis Study (CaMos). Arch Osteoporos. https:\/\/doi.org\/10.1007\/s11657-019-0601-6","journal-title":"Arch Osteoporos"},{"key":"8061_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/AOG.0000000000002096","volume":"130","author":"CJ Crandall","year":"2017","unstructured":"Crandall CJ, Liu J, Cauley J et al (2017) Associations of parity, breastfeeding, and fractures in the Women\u2019s Health Observational Study. Obstet Gynecol 130:171\u2013180. https:\/\/doi.org\/10.1097\/AOG.0000000000002096","journal-title":"Obstet Gynecol"},{"key":"8061_CR21","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/cen.13557","volume":"88","author":"N Hong","year":"2018","unstructured":"Hong N, Kim JE, Lee SJ et al (2018) Changes in bone mineral density and bone turnover markers during treatment with teriparatide in pregnancy- and lactation-associated osteoporosis. Clin Endocrinol (Oxf) 88:652\u2013658. https:\/\/doi.org\/10.1111\/cen.13557","journal-title":"Clin Endocrinol (Oxf)"},{"key":"8061_CR22","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s001980070113","volume":"11","author":"AJ Phillips","year":"2000","unstructured":"Phillips AJ, Ostlere SJ, Smith R (2000) Pregnancy-associated osteoporosis: does the skeleton recover? Osteoporos Int 11:449\u2013454","journal-title":"Osteoporos Int"},{"key":"8061_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00198-017-4239-1","volume":"29","author":"I Kyvernitakis","year":"2018","unstructured":"Kyvernitakis I, Reuter TC, Hellmeyer L et al (2018) Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6\u00a0years of follow-up. Osteoporosis International 29:135\u2013142. https:\/\/doi.org\/10.1007\/s00198-017-4239-1","journal-title":"Osteoporosis International"},{"key":"8061_CR24","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1007\/s00198-023-06927-z","volume":"34","author":"I Kyvernitakis","year":"2023","unstructured":"Kyvernitakis I, Reuter TC, Hellmeyer L et al (2023) Correction to: subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6\u00a0years of follow-up. Osteoporosis International 34:2143\u20132144","journal-title":"Osteoporosis International"},{"key":"8061_CR25","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/s00223-021-00871-y","volume":"109","author":"K Lampropoulou-Adamidou","year":"2021","unstructured":"Hardcastle SA, Yahya F, Bhalla AK (2019) Pregnancy-associated osteoporosis: a UK case series and literature review. Osteoporos Int 30:939\u2013948","journal-title":"Calcif Tissue Int"},{"key":"8061_CR26","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00198-019-04842-w","volume":"30","author":"SA Hardcastle","year":"2019","unstructured":"Lampropoulou-Adamidou K, Trovas G, Triantafyllopoulos IK et al (2021) Teriparatide treatment in patients with pregnancy- and lactation-associated osteoporosis. Calcif Tissue Int 109:554\u2013562. https:\/\/doi.org\/10.1007\/s00223-021-00871-y","journal-title":"Osteoporos Int"},{"key":"8061_CR27","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1007\/s00198-017-4165-2","volume":"28","author":"M Laroche","year":"2017","unstructured":"Laroche M, Talibart M, Cormier C et al (2017) Pregnancy-related fractures: a retrospective study of a French cohort of 52 patients and review of the literature. Osteoporosis International 28:3135\u20133142. https:\/\/doi.org\/10.1007\/s00198-017-4165-2","journal-title":"Osteoporosis International"},{"key":"8061_CR28","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1007\/s00198-006-0112-3","volume":"17","author":"SM O\u2019Sullivan","year":"2006","unstructured":"O\u2019Sullivan SM, Grey AB, Singh R, Reid IR (2006) Bisphosphonates in pregnancy and lactation-associated osteoporosis. Osteoporos Int 17:1008\u20131012. https:\/\/doi.org\/10.1007\/s00198-006-0112-3","journal-title":"Osteoporos Int"},{"key":"8061_CR29","first-page":"94","volume":"52","author":"UC Stumpf","year":"2007","unstructured":"Stumpf UC, Kurth AA, Windolf J, Fassbender WJ (2007) Pregnancy-associated osteoporosis: an underestimated and underdiagnosed severe disease. A review of two cases in short- and long-term follow-up. Adv Med Sci 52:94\u201397","journal-title":"Adv Med Sci"},{"key":"8061_CR30","doi-asserted-by":"publisher","unstructured":"Kaneuchi Y, Iwabuchi M, Hakozaki M et al (2023) Pregnancy and lactation-associated osteoporosis successfully treated with romosozumab: a case report. Medicina (Lithuania) 59. https:\/\/doi.org\/10.3390\/medicina59010019","DOI":"10.3390\/medicina59010019"},{"key":"8061_CR31","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1210\/clinem\/dgad548","volume":"109","author":"P Anagnostis","year":"2024","unstructured":"Anagnostis P, Lampropoulou-Adamidou K, Bosdou JK et al (2024) Comparative effectiveness of therapeutic interventions in pregnancy and lactation-associated osteoporosis: a systematic review and meta-analysis. J Clin Endocrinol Metab 109:879\u2013901","journal-title":"J Clin Endocrinol Metab"},{"key":"8061_CR32","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s12020-024-03946-6","volume":"86","author":"DS Ali","year":"2024","unstructured":"Ali DS, Khan AA, Brandi ML (2024) Effective strategies for pregnancy and lactation-associated osteoporosis: teriparatide use in focus. Endocrine 86:459\u2013469","journal-title":"Endocrine"},{"key":"8061_CR33","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00198-025-07479-0","volume":"36","author":"E Orhadje","year":"2025","unstructured":"Orhadje E, Makaram N, Berg K et al (2025) Clinical presentation, risk factors and management of pregnancy-associated osteoporosis: a systematic review and meta-analysis. Osteoporos Int 36:981\u2013993. https:\/\/doi.org\/10.1007\/s00198-025-07479-0","journal-title":"Osteoporos Int"},{"key":"8061_CR34","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa489","author":"A Cohen","year":"2020","unstructured":"Cohen A, Shiau S, Nair N et al (2020) Effect of teriparatide on bone remodeling and density in premenopausal idiopathic osteoporosis: a phase II trial. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgaa489","journal-title":"J Clin Endocrinol Metab"},{"key":"8061_CR35","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1210\/jc.2013-1172","volume":"98","author":"A Cohen","year":"2013","unstructured":"Cohen A, Stein EM, Recker RR et al (2013) Teriparatide for idiopathic osteoporosis in premenopausal women: a pilot study. J Clin Endocrinol Metab 98:1971\u20131981. https:\/\/doi.org\/10.1210\/jc.2013-1172","journal-title":"J Clin Endocrinol Metab"},{"key":"8061_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00198-011-1560-y","volume":"23","author":"A Cohen","year":"2012","unstructured":"Cohen A, Recker RR, Lappe J et al (2012) Premenopausal women with idiopathic low-trauma fractures and\/or low bone mineral density. Osteoporos Int 23:171\u2013182. https:\/\/doi.org\/10.1007\/s00198-011-1560-y","journal-title":"Osteoporos Int"},{"key":"8061_CR37","doi-asserted-by":"crossref","unstructured":"Neer RM, Arnaud CC, Zanchetta JR et al (2001) The New England Journal of Medicine Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1435-1441","DOI":"10.1056\/NEJM200105103441904"},{"key":"8061_CR38","doi-asserted-by":"crossref","unstructured":"Finkelstein JS, Hayes A, Hunzelman JL et al (2003) The effects of parathyroid hormone, alendronate, or both in men with osteoporosis N Engl J Med 349:1216-1226","DOI":"10.1056\/NEJMoa035725"},{"key":"8061_CR39","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1172\/JCI71101","volume":"124","author":"ES Orwoll","year":"2014","unstructured":"Orwoll ES, Shapiro J, Veith S et al (2014) Evaluation of teriparatide treatment in adults with osteogenesis imperfecta. J Clin Investig 124:491\u2013498. https:\/\/doi.org\/10.1172\/JCI71101","journal-title":"J Clin Investig"},{"key":"8061_CR40","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1210\/en.2006-1467","volume":"148","author":"L Ardeshirpour","year":"2007","unstructured":"Ardeshirpour L, Dann P, Adams DJ et al (2007) Weaning triggers a decrease in receptor activator of nuclear factor-\u03baB ligand expression, widespread osteoclast apoptosis, and rapid recovery of bone mass after lactation in mice. Endocrinology 148:3875\u20133886. https:\/\/doi.org\/10.1210\/en.2006-1467","journal-title":"Endocrinology"},{"key":"8061_CR41","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S0140-6736(13)60856-9","volume":"382","author":"JN Tsai","year":"2013","unstructured":"Tsai JN, Uihlein AV, Lee H et al (2013) Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial. The Lancet 382:50\u201356. https:\/\/doi.org\/10.1016\/S0140-6736(13)60856-9","journal-title":"The Lancet"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08061-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-08061-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08061-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:07:19Z","timestamp":1792271239000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-08061-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["8061"],"URL":"https:\/\/doi.org\/10.1007\/s00198-026-08061-y","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.C. and E.S. receive research support from Amgen, Inc. No other authors have potential conflicts of interest to disclose.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}